Iovance Biotherapeutics Inc (IOVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -27,660 | -12,035 | -25,382 | -3,308 | -25,694 |
| Depreciation Amortization | 999 | 88 | 7 | 504 | 5,003 |
| Accounts payable and accrued liabilities | -290 | N/A | N/A | N/A | N/A |
| Other Working Capital | -243 | -500 | -262 | 4,479 | 360 |
| Other Operating Activity | 8,813 | 3,814 | 21,976 | -3,917 | 14,142 |
| Operating Cash Flow | $-18,381 | $-8,633 | $-3,661 | $-2,242 | $-6,189 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -70,065 | N/A | N/A | N/A | N/A |
| PPE Investments | -1,143 | -1,592 | -13 | N/A | -31 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -50 |
| Investing Cash Flow | $-71,208 | $-1,592 | $-13 | $N/A | $-81 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 311 | 1,481 | 4,615 |
| Common Stock Issued | 78,267 | 3,222 | 7,126 | 250 | 873 |
| Other Financing Activity | 0 | 32,240 | 15,909 | 0 | 0 |
| Financing Cash Flow | $78,267 | $35,462 | $23,346 | $1,731 | $5,488 |
| Beginning Cash Position | 44,909 | 19,672 | N/A | 510 | 1,293 |
| End Cash Position | 33,587 | 44,909 | 19,672 | N/A | 510 |
| Net Cash Flow | $-11,322 | $25,237 | $19,672 | $-510 | $-782 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,381 | -8,633 | -3,661 | -2,242 | -6,189 |
| Capital Expenditure | -1,143 | -1,592 | -13 | N/A | -31 |
| Free Cash Flow | -19,524 | -10,225 | -3,674 | -2,242 | -6,220 |